Nabsys ads

We’re excited to sponsor #ESHG2026 for the very first time! What to expect at ESHG: 📍 A poster presentation highlighting repeat expansion detection with EGM 💡 Discussions on the future of structural variant analysis 🤝 Opportunities to connect with our team at the booth all week long Throughout the conference, Nabsys will be sharing how Electronic Genome Mapping (EGM) is enabling structural variant detection and supporting next-generation genomic research. If you’re attending ESHG, stop by and say hello. We’d love to connect! 👉 Schedule a meeting: https://hubs.ly/Q04j-sHR0 #ESHG #HumanGenetics #EGM #GenomicsResearch

Easily assess the genomic integrity of cells throughout cell stages in your cell and gene therapy analysis. Discover how electronic genome mapping (EGM) captures hidden structural variants that can drive instability in cell lines, iPSCs, and engineered cells.

Bridge the limitations of cytogenetic methods with accessible, high-res genome mapping. Electronic genome mapping detects structural variants and chromosomal aberrations from 300 bp to several megabases. Discover how you can get comprehensive, genome-wide structural variant detection in a single assay.

Screen for off-target effects from gene editing and characterizes on-target editing accessibly and cost-effectively with electronic genome mapping. Our high resolution genome mapping allows you to assess the genomic integrity of cells throughout stages and identifies rearrangements that impact oncogenes or tumor suppressors.

EGM provides clarity to genomic integrity where other tools can’t. Now you can bridge the limitations of cytogenetic methods with accessible, high-res genome mapping—eliminating the need to stitch together results from NGS, microarrays, FISH, and karyotyping.

The RepX Analysis Pipeline delivers a robust and accessible solution for detecting and validating repeat expansions. Discover how you can gain single-molecule clarity and get reproducible analysis in your lab.